πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

2,153 results for β€œOu” Clear

  1. Vantictumab

    Mereo BioPharma Group plc

    Pancreatic Cancer

    phase 1 small molecule completed

    1 trial

  2. Vantictumab combined with paclitaxel

    Mereo BioPharma Group plc

    Metastatic Breast Cancer

    phase 1 small molecule completed

    1 trial

  3. Venetoclax

    Karyopharm Therapeutics Inc

    Acute Leukemia of Ambiguous Lineage in Relapse

    phase 1 small molecule active

    1 trial

  4. Vonoprazan ODT-1 or ODT-2 without Water

    Phathom Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  5. WP1220

    Moleculin Biotech

    Cutaneous T-Cell Lymphoma/Mycosis Fungoides

    phase 1 small molecule completed

    1 trial

  6. WSK-IM05 (4Γ—10^10 vp)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HPV-positive Oropharyngeal Squamous Cell Carcinoma

    phase 1 mab active

    1 trial

  7. WT1-sensitized T cells

    Evidence Based Cataract Study Group

    Leukemia

    phase 1 mab completed

    1 trial

  8. ZG0895 Hydrochloride for Injection

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd

    Advanced Solid Tumor

    phase 1 small molecule active

    1 trial

  9. Zejula 100 mg film-coated tablets, Zejula 100 mg film-coated tablets, JEMPERLI 500 mg concentrate for solution for infusion

    GlaxoSmithKline

    Solid Tumours

    phase 1 small molecule active

    1 trial

  10. [14C]-BMS986504 Mass Balance Study in Patients with Advanced Solid Tumors with Homozygous MTAP Deletion

    Bristol-Myers Squibb Australia Pty Ltd

    Advanced Solid Tumors

    phase 1 other active

    1 trial

  11. acetylsalicylic acid

    United Therapeutics Europe Ltd

    Precancerous Condition

    phase 1 small molecule completed

    1 trial

  12. autologous ET1402L1-CART cells

    AEON Biopharma

    Hepatocellular Carcinoma

    phase 1 mab terminated

    1 trial

  13. autologous FL-33 CAR T therapy

    Universal Integrated

    Refractory/Relapsed Acute Myeloid Leukaemia

    phase 1 small molecule active

    1 trial

  14. autologous cell-based delivery

    Regeneron Ireland Designated Activity Company (DAC)

    Hypoplastic Left Heart Syndrome

    phase 1 mab completed

    1 trial

  15. autologous decidual-like NK cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Abortion, Habitual

    phase 1 mab active

    1 trial

  16. brontictuzumab

    Mereo BioPharma Group plc

    Metastatic Colorectal Cancer

    phase 1 small molecule completed

    1 trial

  17. cyclophosphamide

    Evidence Based Cataract Study Group

    Malignant Pleural Mesothelioma (MPM)

    phase 1 small molecule active

    1 trial

  18. engineered autologous T cells

    United Therapeutics Europe Ltd

    Prostate Cancer

    phase 1 mab active

    1 trial

  19. high-dose Group ACYW135X Meningococcal Conjugate Vaccine

    Sinovac Research and Development Co.,

    Meningococcal Meningitis

    phase 1 mab active

    1 trial

  20. high-fat diet group（AD16 20mgοΌ‰

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Alzheimer Disease

    phase 1 other completed

    1 trial

  21. liposomal cytarabine

    Pacira Ireland Limited

    Brain and Central Nervous System Tumors

    phase 1 small molecule active

    1 trial

  22. milatuzumab

    United Therapeutics Europe Ltd

    Lupus Erythematosus, Cutaneous

    phase 1 small molecule completed

    1 trial

  23. placebo

    Innovent Biologics (Suzhou) Co.

    Healthy

    phase 1 mab completed

    1 trial

  24. randomized, double-blinded, placebo-controlled

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prevention of COVID-19 Caused by SARS-CoV-2

    phase 1 mab active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources